CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Up 8.3% in November

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 15,600 shares, a growth of 8.3% from the October 31st total of 14,400 shares. Based on an average trading volume of 92,100 shares, the short-interest ratio is currently 0.2 days.

CERo Therapeutics Price Performance

NASDAQ:CEROW traded down $0.00 during trading hours on Wednesday, reaching $0.01. The company’s stock had a trading volume of 22,399 shares, compared to its average volume of 68,264. The firm has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.02. CERo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.25.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.